TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 10, 2001, Pages 953-960

  Mizisin, Andrew P ^a,c   Steinhardt, Rachel C ^a   O'Brien, John S ^b   Calcutt, Nigel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetic neuropathy; Nerve conduction velocity; Prosaposin; Prosaptides

Indexed keywords

PEPTIDE DERIVATIVE; PROSAPOSIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFICACY; FEMALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034813173     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.10.953     Document Type: Article

References (33)

1. Aldose reductase inhibitors and their potential for treatment of diabetic complications
2. Clinical trials of diabetic neuropathy: Past, present and future
3. Neurotrophic factors and diabetic neuropathy
4. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats
5. BDNF attenuates functional and structural disorders in nerves of galactose-fed rats
6. NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats
7. Saposin proteins: Structure, function and role in human lysosomal storage disorders
8. Secretion of the sphingolipid hydrolase activator precursor, prosaposin
9. Isolation, characterization and proteolysis of human prosaposin, the precursors of saposins (sphingolipid activator proteins)
10. Cell death prevention, MAP kinase stimulation and enhanced sulfatide synthesis in Schwann cell and oligodendrocyte
11. Prosaposin: A myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury
12. Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury
13. Differentially expressed genes after peripheral nerve injury
14. Prosaptide prevents pacitaxel neurotoxicity
15. Cellular pathology of the nerve microenvironment in galactose intoxication
16. Axon diameters in relation to spike dimensions and the conduction velocity in mammalian A fibers
17. Axon caliber related to neurofilaments and microtubules in sciatic nerve
18. Role of neurofilaments in the control of axonal caliber in myelinated fibers
19. Axonal caliber and neurofilaments are proportionately decreased in galactose neuropathy
20. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats
21. Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes
22. Neurofilament and tubulin gene expression in progressive experimental diabetes. Failure of synthesis and export by sensory neurons
23. Severe radicular pathology in rats with long-standing diabetes
24. Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy
25. Spinal root degeneration in aging laboratory rats: A light microscopic study
26. Radicular myelinopathy in aging rats
27. Degenerative lesions of spinal roots and peripheral nerves in aging rats
28. Triethyltin sulfate-induced splitting of peripheral myelin in rats
29. Hexachlorophene neuropathy in rats
30. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity
31. 6 in rat primary sensory neurons
32. Role of advanced glycation end-products (AGE) in late diabetic complications